SSSandeep Singh

Sandeep Singh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sandeep Singh has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Circadian clock and its effect on aging and lifespan

    by Avnish Kumar Verma, Sandeep Singh, Syed Ibrahim Rizvi

    The circadian clocks of the cell orchestrate a daily transcriptional rhythm that schedules key activities of the cell to maintain homeostasis and support resilience. Circadian rhythm is driven by the periodic oscillations of transcriptional activators and translational repressors, occurring in both the central and peripheral clocks. Accumulating evidence shows that aging impairs the functional synchrony of the circadian system which further escalate age-related disorders. In addition, the technological aspects of modern society, including constant work schedules and extensive use of personal electronics, have led to a significant rise in circadian disorders. Circadian dysfunction seems to adversely impact aging and longevity in animal models. Therefore, it is essential to conduct comprehensive studies to identify factors that worsen with aging and to discover therapeutic options for promoting healthy aging. This review examines how aging affects circadian function and the reciprocal effects of circadian disruption (CD) on aging and longevity. Further, we highlight the recent findings on non-pharmacological aspects such as dietary restrictions and physical exercise as a regulator of circadian rhythms, aging attenuation, and extending lifespan in mammals. Thus, resetting the circadian clock may lead to better synchrony in cellular homeodynamics and physiology which offers healthy aging and increased life span.


  • Neurodegenerative Diseases

    by Sachchida Nand Rai, Sandeep Singh, Santosh Kumar Singh

    This reference book provides a comprehensive overview of models and therapeutic approaches against neurodegenerative diseases, including Parkinson’s disease, Alzheimer’s disease, Huntington’s disease, and amyotrophic lateral sclerosis. It explores models based on the chemical, induced, cellular, genetic, transgenic, and 3D organoid approaches in neurodegenerative diseases. The book also reviews advantages and limitations of these models in designing the treatment strategies. Additionally, the book covers the emerging field of bioinformatics and its application in modeling various neurodegenerative diseases. Towards the end, the book highlights the role of holistic management, precision medicine, OMICS, and gene therapy against neurodegenerative disorders. It examines the implications and significance of stem cells therapy in translational models of neurodegenerative diseases. This book is an invaluable resource for researchers, neuroscientists, and neurosurgeons for getting in-depth information on the neurodegenerative models and therapeutic approaches. Key Features: Provides a comprehensive overview of neurodegenerative diseases and their models Examines the limitations associated with modeling neurodegenerative diseases Presents novel treatment strategies for Alzheimer's disease using cellular models Reviews importance of 3D organoid models for therapeutic approaches in Parkinson's disease Covers modeling techniques in understanding prion diseases Explores the role of genetic models in understanding Huntington's disease


  • Gene Therapy, OMICS Approaches, and Translational Neurodegenerative Models

    by Aakriti Sharma, Shashank Shekhar Mishra, Sandeep Singh

    Gene therapy, OMICS approaches, and translational neurodegenerative models collectively represent a cutting-edge triumvirate at the forefront of addressing neurodegenerative diseases. Gene therapy, through gene replacement, silencing, and editing, aims to correct genetic defects at their source, offering hope for conditions like Alzheimer's and Parkinson's. OMICS technologies – including genomics, transcriptomics, proteomics, and metabolomics – provide a comprehensive view of the molecular intricacies of these diseases, identifying genetic variants, gene expression changes, and protein profiles critical for understanding and developing targeted interventions. Translational neurodegenerative models bridge the gap between bench research and clinical applications, utilising in vitro cell cultures, induced pluripotent stem cells, and organoids to replicate disease complexities observed in humans. These models enhance the reliability and relevance of patient-specific studies, paving the way for personalised treatments. Understanding the molecular basis of neurodegeneration is imperative for advancing therapeutic interventions, offering insights into genetic mutations, abnormal protein aggregations, and disrupted signaling pathways. This knowledge facilitates the development of precise diagnostics, biomarkers, and targeted therapies, potentially halting or reversing disease progression. Gene therapy's evolution, marked by key milestones such as the first clinical trial for Parkinson's disease and the FDA approval for spinal muscular atrophy treatment, underscores its transformative potential. Techniques like CRISPR-Cas9 have further revolutionised the field, enabling precise genetic modifications. This integrated approach, combining gene therapy, OMICS, and translational models, holds promise for innovative and personalised medical interventions, aiming to improve outcomes and quality of life for individuals with neurodegenerative diseases.


  • Spermidine protects cellular redox status and ionic homeostasis in D-galactose induced senescence and natural aging rat models

    by Sandeep Singh, Avnish Kumar Verma, Geetika Garg, Abhishek Kumar Singh, Syed Ibrahim Rizvi

    Impaired redox homeostasis is an important hallmark of aging. Among various anti-aging interventions, caloric restriction mimetics (CRMs) are the most effective in promoting health and longevity. The potential role of spermidine (SPD) as a CRM in modulating oxidative stress and redox homeostasis during aging remains unclear. This study aimed to investigate the protective effect of SPD in D-galactose (D-gal) accelerated induced senescence model and naturally aged rats. Young male rats (4 months), D-gal induced (500 mg/kg b. w., subcutaneously) aging model and naturally aged (22 months) rats were supplemented with SPD (10 mg/kg b. w., orally) for 6 weeks. The results showed that SPD supplementation suppresses the age induced increase in reactive oxygen species, lipid peroxidation and protein oxidation. Additionally, it increases the level of antioxidants, plasma membrane redox system in erythrocytes and membrane. These results also indicate that membrane transporter activity is correlated with the susceptibility of the erythrocyte towards oxidative damage. We therefore present evidence that SPD improves redox status and membrane impairments in erythrocytes in experimental and naturally aging rat models, however, more research is required to recommend a potential therapeutic role for SPD as an anti-aging intervention strategy.


  • Therapeutic potential of melatonin and its derivatives in aging and neurodegenerative diseases

    by Avnish Kumar Verma, Sandeep Singh, Syed Ibrahim Rizvi

    Aging is associated with increasing impairments in brain homeostasis and represents the main risk factor across most neurodegenerative disorders. Melatonin, a neuroendocrine hormone that regulates mammalian chronobiology and endocrine functions is well known for its antioxidant potential, exhibiting both cytoprotective and chronobiotic abilities. Age-related decline of melatonin disrupting mitochondrial homeostasis and cytosolic DNA-mediated inflammatory reactions in neurons is a major contributory factor in the emergence of neurological abnormalities. There is scattered literature on the possible use of melatonin against neurodegenerative mechanisms in the aging process and its associated diseases. We have searched PUBMED with many combinations of key words for available literature spanning two decades. Based on the vast number of experimental papers, we hereby review recent advancements concerning the potential impact of melatonin on cellular redox balance and mitochondrial dynamics in the context of neurodegeneration. Next, we discuss a broader explanation of the involvement of disrupted redox homeostasis in the pathophysiology of age-related diseases and its connection to circadian mechanisms. Our effort may result in the discovery of novel therapeutic approaches. Finally, we summarize the current knowledge on molecular and circadian regulatory mechanisms of melatonin to overcome neurodegenerative diseases (NDDs) such as Alzheimer’s, Parkinson’s, Huntington’s disease, and amyotrophic lateral sclerosis, however, these findings need to be confirmed by larger, well-designed clinical trials. This review is also expected to uncover the associated molecular alterations in the aging brain and explain how melatonin-mediated circadian restoration of neuronal homeodynamics may increase healthy lifespan in age-related NDDs.


  • Recent progress in neuronal intranuclear inclusion disease: a review of the literature

    by Hafiz Khuram Raza, Sandeep Singh, Pabitra Rai, Thitsavanh Chansysouphanthong, Arooj Amir, Guiyun Cui, Wenjing Song, Lei Bao, Su Zhou, Hongjuan Shi, et al.

    To summarize the current understanding of neuronal intranuclear inclusion disease (NIID) and improve the understanding of the physician about this condition.


  • Fisetin, a potential caloric restriction mimetic, attenuates senescence biomarkers in rat erythrocytes

    by Sandeep Singh, Geetika Garg, Abhishek Kumar Singh, Akalabya Bissoyi, Syed Ibrahim Rizvi

    An imbalanced redox status is a hallmark of the aging process. Caloric restriction mimetics (CRMs) are compounds that produce caloric restriction benefits at the molecular, cellular, and physiological level, translating into health-promoting effects. Fisetin is the least explored CRM, and its role in modulating oxidative stress during aging is not clearly known. This study investigated the antioxidative and protective potential of fisetin in a rat model of d-galactose (D-gal)-induced accelerated senescence, and in naturally aged rat erythrocytes. Young rats (4 months), aged D-gal-induced rats [24 months; 500 mg/kg body mass (b.m.); subcutaneous injection] and naturally aged D-gal-induced rats [24 months; 500 mg/kg b.m.; subcutaneous injection] were supplemented with fisetin (15 mg/kg b.m.; orally) for 6 weeks. The resulting data indicated that supplementation with fisetin suppresses aging-induced increases in the levels of reactive oxygen species, eryptosis, lipid peroxidation, and protein oxidation. Our data also show that fisetin significantly increases the levels of antioxidants and activates the plasma membrane redox system. Taken together, the findings show that a fisetin-rich diet could be an anti-aging intervention strategy.


  • Open Access

    Pomegranate (Punica granatum) peel extract provides protection against mercuric chloride-induced oxidative stress in Wistar strain rats

    by Dileep Kumar, Sandeep Singh, Amit Kumar Singh, Syed Ibrahim Rizvi

    Context: Pomegranate [Punica granatum L. (Lythraceae)] is rich in antioxidants. Objective: The present work was undertaken to evaluate the protective effects of methanol extract of pomegranate peel extract (PPE) against a rat model of oxidative stress generated by treatment with mercuric chloride (HgCl2). Materials and methods: Rats were injected with HgCl2 (5 mg/kg body weight in 0.9% NaCl) for developing oxidative stress. The methanol extract of pomegranate peel (PPE) was suspended in 0.5% sodium carboxymethylcellulose and fed to rats at 50 mg/kg body weight/day up to 30 days after HgCl2 treatment. Biomarkers of oxidative stress including erythrocyte plasma membrane redox system (PMRS), lipid peroxidation, advanced oxidation protein products (AOPP), intracellular glutathione, and plasma antioxidant capacity as FRAP values were measured after PPE supplementation. Results: HgCl2-treated rats showed increased oxidative stress as evidenced by increased activity of erythrocyte PMRS 153%, lipid peroxidation 31%, and AOPP 290%. There was a significant (p < 0.01) decrease (25%) in plasma antioxidant capacity and intracellular glutathione (75%). Supplementation with PPE protected rats from HgCl2 induced oxidative damage. PPE supplementation to control rats increased antioxidant defense. Discussion and conclusion: The results clearly demonstrate that PPE treatment augments the antioxidant defense mechanism in mercuric chloride-induced oxidant toxicity. To the best of our knowledge this is the first report of the increase in erythrocyte PMRS activity in rats after supplementation with any kind of antioxidant supplementation. This study emphasizes the need for characterizing PPE for potential unknown antioxidant compounds.